Diwakar Davar
Clinical trials sponsored by Diwakar Davar, explained in plain language.
-
New hope for melanoma patients whose cancer outsmarted standard immunotherapy
Disease control OngoingThis study tests a combination of two experimental drugs (zimberelimab and domvanalimab) in 8 adults with advanced melanoma that stopped responding to standard PD-1 inhibitors. The goal is to see if this new combo can shrink tumors or make them disappear. Participants must have t…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Poop pills meet cancer drugs: study halted before it began
Disease control TerminatedThis study aimed to see if adding a healthy donor fecal transplant (hdFMT) to standard immunotherapy (pembrolizumab/lenvatinib) could help people with advanced melanoma that stopped responding to prior treatment. The trial was withdrawn before enrolling any participants, so no re…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New combo therapy aims to shrink melanoma before surgery
Disease control OngoingThis study tests whether giving immunotherapy drugs before surgery can shrink advanced melanoma (stage III or IV) that can be removed. About 48 adults will receive either one drug (dostarlimab) or two drugs (dostarlimab plus cobolimab) before their operation. The main goal is to …
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated May 06, 2026 16:13 UTC